215 related articles for article (PubMed ID: 27449295)
1. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation.
Wu J; Lei H; Zhang J; Chen X; Tang C; Wang W; Xu H; Xiao W; Gu W; Wu Y
Oncotarget; 2016 Sep; 7(37):58995-59005. PubMed ID: 27449295
[TBL] [Abstract][Full Text] [Related]
2. Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death.
Luo HR; Liu Y; Wan XD; Li JL; Wu M; Zhang QM; Wu DL; Zhao X; Wang TR
Cell Physiol Biochem; 2018; 46(5):1861-1867. PubMed ID: 29705808
[TBL] [Abstract][Full Text] [Related]
3. Momordin Ic induces G0/1 phase arrest and apoptosis in colon cancer cells by suppressing SENP1/c-MYC signaling pathway.
Xianjun F; Xirui X; Jie T; Huiwen M; Shaojun Z; Qiaoyun L; Yunxin L; Xuqun S
J Pharmacol Sci; 2021 Aug; 146(4):249-258. PubMed ID: 34049792
[TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.
Wang C; Tao W; Ni S; Chen Q; Zhao Z; Ma L; Fu Y; Jiao Z
Cancer Sci; 2015 Apr; 106(4):375-82. PubMed ID: 25645686
[TBL] [Abstract][Full Text] [Related]
6. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
[TBL] [Abstract][Full Text] [Related]
7. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y
Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646
[TBL] [Abstract][Full Text] [Related]
8. SUMO-specific protease 1 promotes prostate cancer progression and metastasis.
Wang Q; Xia N; Li T; Xu Y; Zou Y; Zuo Y; Fan Q; Bawa-Khalfe T; Yeh ET; Cheng J
Oncogene; 2013 May; 32(19):2493-8. PubMed ID: 22733136
[TBL] [Abstract][Full Text] [Related]
9. SENP1 regulates PTEN stability to dictate prostate cancer development.
Bawa-Khalfe T; Yang FM; Ritho J; Lin HK; Cheng J; Yeh ET
Oncotarget; 2017 Mar; 8(11):17651-17664. PubMed ID: 27852060
[TBL] [Abstract][Full Text] [Related]
10. SENP1 Interacts with HIF1α to Regulate Glycolysis of Prostatic Carcinoma Cells.
Wang C; Tao W; Ni S; Chen Q
Int J Biol Sci; 2019; 15(2):395-403. PubMed ID: 30745829
[No Abstract] [Full Text] [Related]
11. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis.
Shangguan X; He J; Ma Z; Zhang W; Ji Y; Shen K; Yue Z; Li W; Xin Z; Zheng Q; Cao Y; Pan J; Dong B; Cheng J; Wang Q; Xue W
Nat Commun; 2021 Mar; 12(1):1812. PubMed ID: 33753739
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
Li T; Huang S; Dong M; Gui Y; Wu D
Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.
Wen D; Xiao H; Gao Y; Zeng H; Deng J
Mol Cancer; 2024 May; 23(1):116. PubMed ID: 38822351
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4.
Wu YC; Ling TY; Lu SH; Kuo HC; Ho HN; Yeh SD; Shen CN; Huang YH
Cancer Res; 2012 Oct; 72(19):4963-73. PubMed ID: 23002208
[TBL] [Abstract][Full Text] [Related]
15. SUMO-specific protease 1 modulates cadmium-augmented transcriptional activity of androgen receptor (AR) by reversing AR SUMOylation.
Wu R; Cui Y; Yuan X; Yuan H; Wang Y; He J; Zhao J; Peng S
Toxicol Lett; 2014 Sep; 229(2):405-13. PubMed ID: 25014244
[TBL] [Abstract][Full Text] [Related]
16. SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
Sun XX; Chen Y; Su Y; Wang X; Chauhan KM; Liang J; Daniel CJ; Sears RC; Dai MS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):10983-10988. PubMed ID: 30305424
[TBL] [Abstract][Full Text] [Related]
17. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
Zhu C; Zhu Q; Wu Z; Yin Y; Kang D; Lu S; Liu P
J Cell Physiol; 2018 Feb; 233(2):1104-1119. PubMed ID: 28422286
[TBL] [Abstract][Full Text] [Related]
18. SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors.
Xu Y; Li J; Zuo Y; Deng J; Wang LS; Chen GQ
Cancer Lett; 2011 Oct; 309(1):78-84. PubMed ID: 21669491
[TBL] [Abstract][Full Text] [Related]
19. SENP1 participates in Irinotecan resistance in human colon cancer cells.
Chen MC; Nhan DC; Hsu CH; Wang TF; Li CC; Ho TJ; Mahalakshmi B; Chen MC; Yang LY; Huang CY
J Cell Biochem; 2021 Oct; 122(10):1277-1294. PubMed ID: 34037277
[TBL] [Abstract][Full Text] [Related]
20. MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.
Lemma RB; Ledsaak M; Fuglerud BM; Rodríguez-Castañeda F; Eskeland R; Gabrielsen OS
J Biol Chem; 2023 Sep; 299(9):105062. PubMed ID: 37468105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
